John Murphy, CEO The COVID-19 Long haul Foundation Abstract The global deployment of SARS-CoV-2 vaccines has been accompanied by reports of acute kidney injury (AKI), glomerular disease, interstitial nephritis, podocytopathy […]
The Neurological Sequelae of COVID-19: Long-Term Injury to the Central Nervous System, Neuroimaging, Neuropathology, and Emerging Mechanisms of Long COVID
John Murphy, CEO The COVID-19 Long-haul Foundation Introduction The neurological consequences of SARS-CoV-2 infection have evolved from an initially unexpected collection of clinical observations into a substantial body of neuropathological, […]
Persistent SARS-CoV-2 Reservoirs and the Pathobiology of Long COVID
Etiology, Tissue Persistence, Genomics, Clinical Manifestations, Biomarkers, and Emerging Therapeutic Strategies John Murphy, Chief Executive Officer, The COVID-19 Long-haul Foundation Abstract Background More than four years after the emergence of […]
Long COVID and Dysautonomia: Emerging Insights Into Autonomic Dysfunction, Vagal Pathobiology, Neuroimmune Interactions, and Therapeutic Strategies
John Murphy, M.D., M.P.H., D.P.H. CEO COVID Long-haul Foundation Abstract Background Long COVID, also termed Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), is a complex multisystem disorder characterized by persistent symptoms […]
Long COVID–Associated Vertigo: Etiology, Pathophysiology, Clinical Course, and Therapeutic Strategies
John Murphy, CEO The COVID-19 Long-haul Foundation Introduction Persistent vertigo and disequilibrium have emerged as prominent neurological sequelae of post-acute SARS-CoV-2 infection, commonly termed long COVID. While early pandemic focus […]
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER used many different study methods to understand who is most impacted by Long COVID and why the condition develops. In 2025, the RECOVER Initiative continued to make […]
Post–Acute Sequelae of Long COVID): Comprehensive Clinical Evaluation, Diagnostic Strategy, and Evidence-Based Management
John Murphy, CEO The COVID-19 Long haul Foundation Abstract Post–acute sequelae of SARS-CoV-2 infection (PASC), widely referred to as Long COVID, has emerged as a complex, heterogeneous, and often debilitating […]
Neuropathological Findings in COVID‑19: Autopsy-Based Evidence of Brain Injury
John Murphy, M.D., M.P.H., D.P.H., President Covid-19 Long-haul Foundation Introduction Coronavirus disease 2019 (COVID‑19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), emerged as a global pandemic in early […]
SARS-CoV-2–Associated Injury to Human Epithelial Tissues
Authors: John Murphy, M.D., MPH, DPH. ,Affiliations: President COVID-19 Long-haul FoundationAbstract: 250 words Abstract BackgroundSARS-CoV-2 infection produces multisystem disease with prominent epithelial involvement extending beyond the respiratory tract. Increasing evidence […]
Post-Vaccination Spike Protein Migration: Genomic Mechanisms of Motility, Pathological Spread, and Long-Term Implications
Author: John Murphy, M.D. CEO Covid-19 Long-haul Foundation Abstract Messenger RNA (mRNA) vaccines have revolutionized infectious disease prevention, offering rapid deployment and robust immunogenicity. However, emerging evidence suggests that the […]